S. Kary

2.9k citations

23 papers · 2.2k indexed · 1 hit paper · h-index 19

Impact in

Rheumatology top 0.5%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
Hematology top 1%
- Autoimmune and Inflammatory Disorders Research

Papers in

Rheumatology 23
- Rheumatoid Arthritis Research and Therapies 19
- Spondyloarthritis Studies and Treatments 11
- Systemic Lupus Erythematosus Research 4
Hematology 12
- Autoimmune and Inflammatory Disorders Research 12

Co-authors: H. Küpper Martina Kron Martín Rudwaleit A. Zink Joachim Listing Christian Antoni Kristina Unnebrink Gerd R Burmester
Journals: Annals of the Rheumatic Diseases (5 papers)Lara D. Veeken (4 papers)Arthritis Research & Therapy (3 papers)The Journal of Rheumatology (2 papers)Clinical and Experimental Rheumatology (1 paper)
Partner nations: Germany United States France

In The Last Decade

S. Kary

23 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

Infections in patients with rheumatoid arthritis treated with biologic agents 2005 · 512 citations

Peers

Countries citing papers authored by S. Kary

Since Specialization

Citations

This map shows the geographic impact of S. Kary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Kary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Kary more than expected).

Fields of papers citing papers by S. Kary

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Kary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Kary. The network helps show where S. Kary may publish in the future.

Co-authorship network

The 25 scholars most cited alongside S. Kary, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Kary Line = papers co-authored together S. Kary links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab Lara D. Veeken ·Désirée van der Heijde, Maxime Bréban, D Halter, Celso Carvalho, Johan Bratt, Fabrizio Cantini, S. Kary, Aileen L. Pangan, H. Küpper, Suchitrita S. Rathmann, Joachim Sieper, Phillip J. Mease	2014	42
2	Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy Arthritis Research & Therapy ·Martín Rudwaleit, Filip Van den Bosch, Martina Kron, S. Kary, H. Küpper	2010	74
3	Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis Arthritis Research & Therapy ·Martín Rudwaleit, Pascal Claudepierre, Martina Kron, S. Kary, Robert Wong, H. Küpper	2010	27
4	Clinical manifestations and responsiveness to adalimumab are similar in patients with ankylosing spondylitis with and without concomitant psoriasis Lara D. Veeken ·Jürgen Braun, Martín Rudwaleit, S. Kary, Martina Kron, Robert Wong, H. Küpper	2010	24
5	Effectiveness, Safety, and Predictors of Good Clinical Response in 1250 Patients Treated with Adalimumab for Active Ankylosing Spondylitis The Journal of Rheumatology ·Martín Rudwaleit, Pascal Claudepierre, P Wordsworth, 石村佳代子, Joachim Sieper, Martina Kron, Joyce Huang, H. Küpper, S. Kary	2009	170
6	Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions Annals of the Rheumatic Diseases ·Filip Van den Bosch, Bernhard Manger, Philippe Goupille, Neil McHugh, E Rødevand, Peter Holck, Ronald van Vollenhoven, Marjatta Leirisalo‐Repo, Oliver FitzGerald, Martina Kron, Michael Frank, S. Kary, H. Küpper	2009	100
7	Predictors of good clinical response (BASDAI 50 or ASAS partial remission) in 1,250 patients treated with adalimumab (humira (R)) for active ankylosing spondylitis (AS) Clinical and Experimental Rheumatology ·Martín Rudwaleit, Pascal Claudepierre, P Wordsworth, Estíbaliz Loza, Ruey‐Hong Wong, M. Kron, S. Kary, H. Küpper	2008	2
8	An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status Clinical Rheumatology ·A. E. van der Bijl, Ferdinand C. Breedveld, Christian Antoni, Joachim R. Kalden, S. Kary, Gerd R Burmester, Christina Beckmann, Kristina Unnebrink, H. Küpper	2008	69
9	Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study Annals of the Rheumatic Diseases ·Martín Rudwaleit, E Rødevand, Peter Holck, J. Vanhoof, Martina Kron, S. Kary, H. Küpper	2008	208
10	Remission and major clinical response in active rheumatoid arthritis (RA) patients after adalimumab (Humira (R)) treatment Lara D. Veeken ·Hugo Hübl, P Wordsworth, Frank McKenna, A.O. Stopakevych, Zhengsong Lu, S. Kary, H. Küpper	2007	1
11	Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice Lara D. Veeken ·Stefano Bombardieri, Lukas Sönning, Patrice Fardellone, Piet Geusens, Frank McKenna, Kristina Unnebrink, Shlomit Shachor, S. Kary, H. Küpper, G. R. Burmester	2007	153
12	Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-? antagonists British Journal of Dermatology ·郑姗, Oluwafemi Samson Olagbami, Fu-Ren Lin, G. BAIST., J. Detert, Joachim Röwert, Heike Audring, S. Kary, Gerd R Burmester, Wolfram Sterry, Margitta Worm	2007	169
13	Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial Annals of the Rheumatic Diseases ·Gerd R Burmester, X. Mariette, Carlomaurizio Montecucco, Neeta Singh, Michel Malaise, Athanasios G. Tzioufas, J. W. J. Bijlsma, Kristina Unnebrink, S. Kary, H. Küpper	2007	162
14	Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open‐label, twelve‐week study Arthritis Care & Research ·Gerd R Burmester, Gianfranco Ferraccioli, René‐Marc Flipo, Neeta Singh, Kristina Unnebrink, S. Kary, H. Küpper	2007	83
15	New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor α antagonists Annals of the Rheumatic Diseases ·S. Kary, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2005	85
16	Infections in patients with rheumatoid arthritis treated with biologic agents Arthritis & Rheumatism ·Joachim Listing, Anja Strangfeld, S. Kary, Rolf Rau, 游小叶, SEPTEFIANO KAJU KEVIN, Erika Gromnica‐Ihle, Christian Antoni, P. Herzer, Jörn Kekow, Matthias Schneider, A. Zink Hit paper breakdown →	2005	512
17	Treatment continuation in patients receiving biological agents or conventional DMARD therapy Annals of the Rheumatic Diseases ·A. Zink, Joachim Listing, S. Kary, 茂也森, SEPTEFIANO KAJU KEVIN, Zinnia Madon, 游小叶, Erika Gromnica‐Ihle, S Wassenberg, Christian Antoni, P. Herzer, Jörn Kekow, Matthias Schneider, R. Rau	2005	126
18	Pharmakotherapie rheumatischer Erkrankungen im Alter Der Internist ·S. Kary, Frank Buttgereit, G.-R. Burmester	2003	1
19	Therapie der rheumatoiden Arthritis bei Erwachsenen mit Biologika Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz ·S. Kary, G.-R. Burmester	2002	1
20	Oral type II collagen treatment in early rheumatoid arthritis. A double‐blind, placebo‐controlled, randomized trial Arthritis & Rheumatism ·Joachim Sieper, S. Kary, H. Sörensen, Rieke Alten, U. Eggens, Katsushi KUWAMURA, Falk Hiepe, W. Schneider, Joachim Listing, Norbert Ulbrich, Jürgen Braun, A. Zink, N Mitchison	1996	121

About S. Kary

S. Kary is a scholar working on Rheumatology, Hematology, Genetics, Immunology and Pathology and Forensic Medicine, having authored 23 papers that have together received 2.2k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (19 papers), Autoimmune and Inflammatory Disorders Research (12 papers), Spondyloarthritis Studies and Treatments (11 papers), Psoriasis: Treatment and Pathogenesis (7 papers), Chronic Lymphocytic Leukemia Research (4 papers), Systemic Lupus Erythematosus Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Rheumatology (1.6k citations), Hematology (668 citations), Immunology (876 citations), Genetics (223 citations) and Ophthalmology (162 citations). S. Kary has collaborated with scholars based in Germany, United States and France. Frequent co-authors include H. Küpper, Martina Kron, Martín Rudwaleit, A. Zink, Joachim Listing, Christian Antoni, Kristina Unnebrink, Gerd R Burmester, Jörn Kekow and Erika Gromnica‐Ihle. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Arthritis Research & Therapy, The Journal of Rheumatology and Clinical and Experimental Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact